Heart Failure-Wii study

28 August 2017 (09:15 - 09:30)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Tiny Jaarsma

Linkoping University, Linkoping (Sweden)

5 More presentations in this session

Presentation thumbnail

Heart failure and death in new users of SGLT2 inhibitors vs other glucose-lowering drugs - consistent risk reduction across patient groups in 4 countries and >270,000 patients: The CVD-REAL Study

Professor A. Norhammar (Stockholm, SE)

Presentation thumbnail

Efficacy of beta-blockers in heart failure according to left ventricular ejection fraction: An individual patient level analysis of double-blind randomised trials

Professor D. Kotecha (Birmingham, GB)

Presentation thumbnail

Marked variation in the efficacy of beta-blockers across cardiovascular health: A Global systematic assessment of mortality, myocardial infarction and stroke

Doctor O. Ziff (Birmingham, GB)

Presentation thumbnail

Does the risk for heart failure (HF) modulate the effectiveness of empagliflozin on HF hospitalisation or CV death in patients with type 2 diabetes without HF? Insights from EMPA-REG OUTCOME

Professor J. Butler (Dallas, US)

Presentation thumbnail

Predicting right heart failure after implantation of continuous flow left ventricular assist devices (EUROMACS-RHF) score: analysis of the EUROMACS data

Professor O. Soliman (Dublin, IE)

Access the full session

Session thumbnail

Late-Breaking Science in Heart Failure

The Event

ESC Congress 2017

28 August 2017 09:15 CET

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources